Optimizing Biomarker-Based Decision-Making for Patients with Non-Small Cell Lung Cancer with EGFR Mutations or with Other Oncogene-Addicted Lung Cancers - 10/26/2021
1:05:01
2021 Webinar Archive
Optimizing Biomarker-Based Decision-Making for Patients with Non-Small Cell Lung Cancer with EGFR Mutations or with Other Oncogene-Addicted Lung Cancers - 10/26/2021
2021 Webinar Archive Similar Videos
Similar Videos
-
Key Considerations in the Management of Patients with Small Cell Lung Cancer - 11/4/2021
1:02:34
-
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma (Part 3 of a 4-Part Series) - 12/10/2021
2:00:27
-
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia (Part 1 of a 4-Part Series) - 12/20/2021
2:02:12